← Back to directory

Evandro de Azambuja

Researcher Next ID · RN-007737

Researcher · Medicine

Université Libre de Bruxelles

Brussels, Belgium

Not currently recruitingFunding unknown
Works count
726
Citation count
39,976
H-index
87
i10-index
289

Research interests

Medicine
Biochemistry, Genetics and Molecular Biology
HER2/EGFR in Cancer Research
Breast Cancer Treatment Studies
Advanced Breast Cancer Therapies
Cancer Treatment and Pharmacology
Estrogen and related hormone effects

Publications

  • 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)

    European Heart Journal · 2022 · https://doi.org/10.1093/eurheartj/ehac244

  • Adjuvant Olaparib for Patients with BRCA1 - or BRCA2 -Mutated Breast Cancer

    New England Journal of Medicine · 2021 · https://doi.org/10.1056/nejmoa2105215

  • ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer

    Annals of Oncology · 2021 · https://doi.org/10.1016/j.annonc.2021.09.019

  • Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer

    New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1703643

  • Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98

    Journal of Clinical Oncology · 2013 · https://doi.org/10.1200/jco.2011.41.0902

Current projects

    No projects listed.